# In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.

> **NCT00788255** · — · COMPLETED · sponsor: **Stanford University** · enrollment: 25 (actual)

## Conditions studied

- Anesthesia

## Interventions

- **DRUG:** Final exogenous oxytocin concentration=22.5 μU/mL
- **DRUG:** Final exogenous oxytocin concentration=30.1μU/mL
- **DRUG:** Final exogenous oxytocin concentration=32.9μU/mL

## Key facts

- **NCT ID:** NCT00788255
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788255, "In-vitro Study to Assess the Coagulation Effects of Exogenous Oxytocin Using Thromboelastography.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00788255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*